How fat could help solve part of the diabetes problem

October 29, 2013
How fat could help solve part of the diabetes problem

The pancreas is a large organ that wraps around our gut, and produces the exact amount of insulin our bodies need when we eat – except when we start to develop diabetes, and insulin production slows down. Sydney scientists describe how a fat recycling system within pancreatic 'beta cells' determines the amount of insulin they secrete, and so may provide a target for future diabetes therapies.

A small structure inside the beta cell, known as a 'lysosome', behaves like an intracellular recycling unit. It breaks down unwanted fats and proteins in such a way that they can be re-used.

PhD student Gemma Pearson and Professor Trevor Biden from Sydney's Garvan Institute of Medical Research showed that when they prevented lysosomes from breaking down , beta cells secreted more insulin. Their study is published in Diabetologia, now online.

While this is a very early stage cell biology story, it nonetheless holds promise, and encourages the scientific community to look at therapies through a fatty lens.

"There are many different ways fats can be used within the beta cell – so if you stop them being recycled, you force them to be used in a different way," said Gemma Pearson, whose PhD examines the "lipid profile" of beta cells.

"When you shift fats from the lysosome, you store them in other parts of the cell, and they become available to participate in various signaling pathways. One of these pathways clearly increases ."

"Fat molecules are not the inert blobs you might think – they can bind to proteins and activate them, causing a range of downstream events to occur."

"The good thing about this particular pathway is that it is only stimulated by glucose. That limits the beta cell to producing excess insulin only to deal with food, rather than around the clock. Too much circulating in the blood, or hyperinsulinaemia, can be very detrimental to health in many respects."

"If in future a drug were to be developed to block fat degradation in the lysosome, it would have to be tweaked to affect only."

Explore further: Study identifies immune cells that promote growth of beta cells in type 1 diabetes

More information: link.springer.com/article/10.1 … %2Fs00125-013-3083-x

Related Stories

Study identifies immune cells that promote growth of beta cells in type 1 diabetes

September 27, 2013
Joslin researchers have identified immune cells that promote growth of beta cells in type 1 diabetes. This study provides further evidence of a changed role for immune cells in type 1 diabetes pathology. The study appears ...

No rebirth for insulin secreting pancreatic beta cells

April 24, 2013
Pancreatic beta cells store and release insulin, the hormone responsible for stimulating cells to convert glucose to energy. The number of beta cells in the pancreas increases in response to greater demand for insulin or ...

Insulin 'still produced' in most people with type 1 diabetes

October 9, 2013
New technology has enabled scientists to prove that most people with type 1 diabetes have active beta cells, the specialised insulin-making cells found in the pancreas. Type 1 diabetes occurs when the body's immune system ...

Fractalkine: New protein target for controlling diabetes

April 11, 2013
Researchers at the University of California, San Diego School of Medicine have identified a previously unknown biological mechanism involved in the regulation of pancreatic islet beta cells, whose role is to produce and release ...

New mechanism regulating insulin secretion may explain genetic susceptibility to diabetes

February 4, 2013
New Zealand research revealing a new mechanism for how glucose stimulates insulin secretion may provide a new explanation for how a gene that makes people more susceptible to diabetes – called TCF7L2 – actually contributes ...

Recommended for you

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017
Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.